How Much Did Mosaic TX Raise?
Funding & Key Investors

Mosaic TX has secured $28M in total capital, with a recent strategic investment of $28M marking a significant milestone in its Series A financing round. This major enterprise-level funding underscores the company's advanced stage in developing targeted oncology therapeutics.

What is Mosaic TX?

Mosaic TX
ManufacturingPharmaceuticalsBusiness Services

Mosaic Therapeutics is an oncology therapeutics company dedicated to discovering and developing novel targeted drug combinations for cancer treatment. By focusing on biomarker-defined settings and leveraging a unique blend of experimental biology and computational platforms, Mosaic aims to significantly improve patient outcomes. The company's strategy involves molecularly-guided stratification of precision medicines to deliver more effective and less toxic therapies. Their robust partnerships, including a notable alliance with the Wellcome Sanger Institute, bolster their capabilities in advancing cancer care.

How much funding has Mosaic TX raised?

Mosaic TX has raised a total of $28M across 1 funding round:

2023

Series A

$28M

Series A (2023): $28M with participation from Syncona and Cambridge Innovation Capital

Key Investors in Mosaic TX

Syncona

Syncona is a FTSE250 company focused on founding and funding healthcare ventures that aim to deliver transformative treatments for patients with significant unmet medical needs. They manage a diverse portfolio of life science companies, investing strategically to maximize value through key inflection points.

Cambridge Innovation Capital

Cambridge Innovation Capital is a venture investor specializing in the Cambridge ecosystem, backing innovative start-ups in life sciences and deep tech. They provide crucial financial backing and expert guidance to help pioneering companies achieve their vision.

What's next for Mosaic TX?

The recent major strategic investment positions Mosaic TX for accelerated growth and the scaling of its therapeutic development pipeline. This Series A financing is expected to fuel the expansion of its research and development efforts, potentially leading to the advancement of its drug combination candidates through clinical trials. The company's focus on precision medicine and its strong scientific foundation suggest a trajectory aimed at addressing substantial unmet needs in oncology, with future developments likely centered on strategic partnerships and pipeline progression.

See full Mosaic TX company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ManufacturingMedical Devices & Equipment
Building MaterialsManufacturingFurniture
Industrial Machinery & EquipmentManufacturingConsumer ServicesOther Rental Stores (Furniture, A/V, Construction & Industrial Equipment)RetailAutomotive Service & Collision Repair
ManufacturingToys & GamesSporting Goods

Frequently Asked Questions Regarding Mosaic TX Financial Insights

What are the most recent funding rounds that Mosaic TX has completed, and what were the funding rounds?
Mosaic TX has recently completed 1 funding rounds: Series A on Apr 4, 2023.
What is the total amount of funding Mosaic TX has raised to date?
Mosaic TX has raised a total of $28M in funding to date.
How many funding rounds has Mosaic TX completed?
Mosaic TX has completed 1 funding rounds.
How much funding did Mosaic TX raise in its most recent funding round?
Mosaic TX raised $28M in its most recent funding round.
Who are the lead investors in Mosaic TX's latest funding round?
The lead investor in Mosaic TX's latest funding round was Syncona. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Mosaic TX's history?
The largest funding round in Mosaic TX's history was $28M.
See more information about Mosaic TX